NATCOPHARM.NS Balance Sheet

NATCO Pharma Ltd.

Balance Sheet · 6 years on file (FY2020-21 to FY2025-26) · fetched 2026-08-23 23:38

Line item	FY2020-21	FY2021-22	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Property, Plant and Equipment	N/A	N/A	₹22.39 Bn	₹22.98 Bn	₹24.32 Bn	₹25.45 Bn	PropertyPlantAndEquipment
Capital Work-in-Progress	N/A	N/A	₹0.64 Bn	₹1.37 Bn	₹2.25 Bn	₹2.94 Bn	CapitalWorkInProgress
Goodwill	N/A	N/A	₹0.55 Bn	₹0.56 Bn	₹0.57 Bn	₹0.63 Bn	Goodwill
Other Intangible Assets	N/A	N/A	₹1.33 Bn	₹1.37 Bn	₹2.09 Bn	₹1.94 Bn	OtherIntangibleAssets
Non-current Investments	N/A	N/A	₹0.87 Bn	₹0.96 Bn	₹1.53 Bn	₹2.73 Bn	NoncurrentInvestments
Other Non-current Assets	N/A	N/A	₹0.27 Bn	₹0.95 Bn	₹0.52 Bn	₹0.81 Bn	OtherNoncurrentAssets
Total Non-current Assets	N/A	N/A	₹26.57 Bn	₹28.83 Bn	₹33.61 Bn	₹60.21 Bn	NoncurrentAssets
Inventories	N/A	N/A	₹7.43 Bn	₹7.00 Bn	₹7.66 Bn	₹9.09 Bn	Inventories
Trade Receivables	N/A	N/A	₹8.56 Bn	₹11.89 Bn	₹12.47 Bn	₹8.81 Bn	TradeReceivablesCurrent
Cash and Cash Equivalents	N/A	N/A	₹1.32 Bn	₹0.70 Bn	₹1.20 Bn	₹1.99 Bn	CashAndCashEquivalents
Current Investments	N/A	N/A	₹3.05 Bn	₹4.43 Bn	₹3.21 Bn	₹5.78 Bn	CurrentInvestments
Other Current Assets	N/A	N/A	₹2.29 Bn	₹2.76 Bn	₹3.31 Bn	₹3.82 Bn	OtherCurrentAssets
Total Current Assets	N/A	N/A	₹30.00 Bn	₹40.23 Bn	₹52.70 Bn	₹50.52 Bn	CurrentAssets
Total Assets	N/A	N/A	₹56.57 Bn	₹69.06 Bn	₹86.31 Bn	₹110.74 Bn	Assets
Equity Share Capital	N/A	N/A	₹0.36 Bn	₹0.36 Bn	₹0.36 Bn	₹0.36 Bn	EquityShareCapital
Other Equity	N/A	N/A	₹48.37 Bn	₹58.17 Bn	₹75.71 Bn	₹91.85 Bn	OtherEquity
Equity Attributable to Owners	N/A	N/A	₹48.74 Bn	₹58.53 Bn	₹76.07 Bn	₹92.21 Bn	EquityAttributableToOwnersOfParent
Non-controlling Interests	N/A	N/A	N/A	N/A	₹0.05 Bn	₹0.00 Bn	NonControllingInterest
Total Equity	N/A	N/A	₹48.74 Bn	₹58.53 Bn	₹76.12 Bn	₹92.21 Bn	Equity
Long-term Borrowings	N/A	N/A	₹0.00 Bn	₹0.00 Bn	₹0.00 Bn	₹1.00 Bn	BorrowingsNoncurrent
Total Non-current Liabilities	N/A	N/A	₹1.00 Bn	₹0.80 Bn	₹0.75 Bn	₹1.72 Bn	NoncurrentLiabilities
Short-term Borrowings	N/A	N/A	₹1.65 Bn	₹3.63 Bn	₹2.73 Bn	₹6.06 Bn	BorrowingsCurrent
Trade Payables	N/A	N/A	₹2.64 Bn	₹2.35 Bn	₹2.75 Bn	₹4.09 Bn	TradePayablesCurrent
Other Current Liabilities	N/A	N/A	₹1.41 Bn	₹1.34 Bn	₹1.22 Bn	₹1.73 Bn	OtherCurrentLiabilities
Total Current Liabilities	N/A	N/A	₹6.83 Bn	₹9.73 Bn	₹9.44 Bn	₹16.81 Bn	CurrentLiabilities
Total Equity and Liabilities	N/A	N/A	₹56.57 Bn	₹69.06 Bn	₹86.31 Bn	₹110.74 Bn	EquityAndLiabilities

Every figure above is the exact value of the named XBRL element from NATCOPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).